Eszopiclone Co-Administered With Fluoxetine in Patients With Insomnia Coexisting With Major Depressive Disorder

Fava, Maurizio, McCall, W. Vaughn, Krystal, Andrew, Wessel, Thomas, Rubens, Robert, Caron, Judy, Amato, David, Roth, Thomas·2006·Biological Psychiatry
DOI 10.1016/j.biopsych.2006.01.016

Cited by (479)

Items 101–200 of 479

  1. Severe insomnia is associated with more severe presentation and greater functional deficits in depression
    Erin M. O’Brien, Iwona Chelminski, Diane Young, Kristy L. Dalrymple, Joshua I. Hrabosky, Mark A. Zimmerman · 2011 · Journal of Psychiatric Research
  2. Insomnia and Depression
    Daniel J. Taylor · 2008 · SLEEP
  3. Evaluation of the PHQ-9 Item 3 as a Screen for Sleep Disturbance in Primary Care
    Kristin L. MacGregor, Jennifer Schum Funderburk, Wilfred R. Pigeon, Stephen A. Maisto · 2011 · Journal of General Internal Medicine
  4. Pharmacological Treatment of Insomnia
    Paula Klingenberg Schweitzer, Stephen D. Feren · 2016 · Springer eBooks
  5. Chronic Insomnia
    Daniel J. Buysse · 2008 · American Journal of Psychiatry
  6. Cocaine and Sleep: Early Abstinence
    PETER T. MORGAN, Robert T. Malison · 2007 · The Scientific World JOURNAL
  7. Diagnosis, prevalence, pathways, consequences & treatment of insomnia.
    Wilfred R. Pigeon · 2010 · PubMed
  8. Decomposing depression: on the prospective and reciprocal dynamics of mood and sleep disturbances.
    D. Sbarra, John J. B. Allen · 2009 · Journal of Abnormal Psychology
  9. Functional and structural brain alterations in insomnia: implications for pathophysiology
    Dieter Wilhelm Riemann, CORINNA KLOEPFER, Thomas Berger · 2009 · European Journal of Neuroscience
  10. The effects of exercise on sleep in unipolar depression: a systematic review and network meta-analysis
    Brupbacher, Gavin, Gerger, Heike, Zander-Schellenberg, Thea, Straus, Doris, Porschke, Hildburg, Gerber, Markus, von Känel, Roland, Schmidt-Trucksäss, Arno · 2021 · Sleep Medicine Reviews
  11. Meta-Analyses of Hypnotics and Infections: Eszopiclone, Ramelteon, Zaleplon, and Zolpidem
    Joya, Florendo L., Kripke, Daniel F., Loving, Richard T., Dawson, Arthur, Kline, Lawrence E. · 2009 · Journal of Clinical Sleep Medicine
  12. Sleep and Psychiatric Disorders: Future Directions
    Andrew D. Krystal · 2006 · Psychiatric Clinics of North America
  13. The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect
    Karolina Pytka, Anna Dziubina, Katarzyna Młyniec, Agnieszka Dziedziczak, Elżbieta Żmudzka, Anna Furgała, Adrian Olczyk, Jacek Sapa, Barbara Filipek · 2015 · Pharmacological Reports
  14. Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment
    Franzen, Peter L., Buysse, Daniel J., Rabinovitz, Mordechai, Pollock, Bruce G., Lotrich, Francis E. · 2010 · Psychiatry Research
  15. Effects of integrated telehealth-delivered cognitive-behavioral therapy for depression and insomnia in rural older adults.
    Forrest R. Scogin, Kenneth L. Lichstein, Elizabeth A. DiNapoli, Julie A. Woosley, Stephen Justin Thomas, Michael A. LaRocca, Haley D. Byers, Lisa Mieskowski, Christina Pierpaoli Parker, Xin Thomas Yang et al. · 2018 · Journal of Psychotherapy Integration
  16. Does exercise improve self-reported sleep quality in non-remitted major depressive disorder?
    Chad D. Rethorst, Prabha Sunderajan, Tracy L. Greer, Bruce D. Grannemann, Paul A. Nakonezny, Thomas James Carmody, Madhukar H. Trivedi · 2012 · Psychological Medicine
  17. Does Effective Management of Sleep Disorders Reduce Depressive Symptoms and the Risk of Depression?
    Dieter Wilhelm Riemann · 2009 · Drugs
  18. Sleep, circadian rhythms, and schizophrenia
    Jan Cosgrave, Katharina Wulff, Philip Gehrman · 2018 · Current Opinion in Psychiatry
  19. Predictors of dropout from internet-based self-help cognitive behavioral therapy for insomnia
    Wing‐Fai Yeung, Ka‐Fai Chung, Fiona Yan‐Yee Ho, LM Ho · 2015 · Behaviour Research and Therapy
  20. Eszopiclone: A Review of Its Use in the Treatment of Insomnia
    Hair, Philip I, McCormack, Paul L, Curran, Monique P · 2008 · Drugs
  21. Genetic and Environmental Influences on Sleep, Pain, and Depression Symptoms in a Community Sample of Twins
    Marianna Gasperi, Matthew Scott Herbert, Ellen A. Schur, Dedra Buchwald, Niloofar Afari · 2017 · Psychosomatic Medicine
  22. Eszopiclone for insomnia
    Susanne Rösner, Christian Englbrecht, Renate Wehrle, Göran Hajak, Michael Soyka · 2018 · Cochrane Database of Systematic Reviews
  23. Nonpharmacologic Management of Chronic Insomnia.
    David L Maness, Muneeza Khan · 2015 · PubMed
  24. Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness
    Boadie Waid Dunlop, Paul F. Crits-Christoph, Dwight L. Evans, Jack Hirschowitz, H. Brent Solvason, Karl Rickels, Steven J. Garlow, Robert Gallop, Philip T. Ninan · 2007 · Journal of Clinical Psychopharmacology
  25. L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive Episode.
    Lawrence D. Ginsberg, Alondra Oubré, Yahya Daoud · 2011 · PubMed Central
  26. The Effectiveness of Light/Dark Exposure to Treat Insomnia in Female Nurses Undertaking Shift Work during the Evening/Night Shift
    Huang, Li-Bi, Tsai, Mei-Chu, Chen, Ching-Yen, Hsu, Shih-Chieh · 2013 · Journal of Clinical Sleep Medicine
  27. A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.
    J. M. Bostwick · 2010 · Mayo Clinic proceedings
  28. Altered GABAergic and glutamatergic activity within the rat hippocampus and amygdala in rats subjected to repeated corticosterone administration but not restraint stress
    April L. Lussier, Raquel Romay-Tallón, Héctor J. Caruncho, Lisa E. Kalynchuk · 2012 · Neuroscience
  29. Evidence-Based Applications of Combination Psychotherapy and Pharmacotherapy for Depression
    Boadie Waid Dunlop · 2016 · FOCUS The Journal of Lifelong Learning in Psychiatry
  30. New guidelines for diagnosis and treatment of insomnia
    Luciano Ribeiro Pinto, Rosana Cardoso Alves, Eliazor Campos Caixeta, John Araujo Fontenelle, Andrea Bacellar, Dalva Rollemberg Poyares, Flávio Alóe, Geraldo Nunes Vieira Rizzo, Gisele Richter Minhoto, Lia Bittencourt et al. · 2010 · Arquivos de Neuro-Psiquiatria
  31. Next‐day cognition, psychomotor function, and driving‐related skills following nighttime administration of eszopiclone
    Julia Boyle, Leanne Trick, Sigurd Johnsen, James M. Roach, Robert Rubens · 2008 · Human Psychopharmacology Clinical and Experimental
  32. Predisposition in the Evolution of Insomnia: Evidence, Potential Mechanisms, and Future Directions
    Christopher Lawrence Drake, Thomas G. Roth · 2006 · Sleep Medicine Clinics
  33. The Modulation of Synaptic GABAA Receptors in the Thalamus by Eszopiclone and Zolpidem
    Fan Jia, Peter A. Goldstein, Neil L. Harrison · 2008 · Journal of Pharmacology and Experimental Therapeutics
  34. Emerging drugs for insomnia: new frontiers for old and novel targets
    Shannon S. Sullivan, Christian Guilleminault · 2009 · Expert Opinion on Emerging Drugs
  35. Why Treat Insomnia?
    Sara E. Matteson-Rusby, Wilfred R. Pigeon, Philip Gehrman, Michael Lloyd Perlis · 2010 · The Primary Care Companion to The Journal of Clinical Psychiatry
  36. A Polysomnographic Placebo-Controlled Evaluation of the Efficacy and Safety of Eszopiclone Relative to Placebo and Zolpidem in the Treatment of Primary Insomnia
    Milton K. Erman, Gary K Zammit, Robert Rubens, Kendyl Schaefer, Thomas C. Wessel, David A. Amato, Judy Caron, James K. Walsh · 2008 · Journal of Clinical Sleep Medicine
  37. Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study.
    David V. Sheehan, Harry A. Croft, E. Roderich Gossen, Randy J. Levitt, Claire Brullé, Sylvie Bouchard, Anna Rozova · 2009 · PubMed Central
  38. Buprenorphine Disrupts Sleep and Decreases Adenosine Concentrations in Sleep-regulating Brain Regions of Sprague Dawley Rat
    Elizabeth A. Gauthier, Sarah E. Guzick, Chad M. Brummett, Helen A. Baghdoyan, Ralph Lydic · 2011 · Anesthesiology
  39. Psychiatric outcome studies (POS): Does treatment help the patients? A Popperian approach to research in clinical psychiatry
    Per Bech, M. Lunde, G. Bech-Andersen, Lone Lindberg, Klaus Martiny · 2007 · Nordic Journal of Psychiatry
  40. Effectiveness of Benzodiazepine Receptor Agonists in the Treatment of Insomnia: An Examination of Response and Remission Rates
    Vivek Pillai, Thomas G. Roth, Timothy Roehrs, Kenneth Moss, Edward L. Peterson, Christopher Lawrence Drake · 2016 · SLEEP
  41. Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons
    Jared Minkel, A. Krystal · 2013 · Sleep Medicine Clinics
  42. A validation analysis of two self‐reported HAM‐D6 versions
    Per Bech, Peter Henry Wilson, Thomas C. Wessel, M. Lunde, Maurizio Fava M. D · 2008 · Acta Psychiatrica Scandinavica
  43. Major depression: emerging therapeutics
    Srijan Sen, Gerard Sanacora · 2008 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
  44. Sleep in Mood Disorders
    Michael J. Peterson, Ruth M. Benca · 2008 · Sleep Medicine Clinics
  45. Familiality and clinical outcomes of sleep disturbances in major depressive and bipolar disorders
    Yin-Chieh Lai, Ming‐Chyi Huang, Hsi‐Chung Chen, Ming-Kun Lu, Yi-Hang Chiu, Winston W. Shen, Ru‐Band Lu, Po‐Hsiu Kuo · 2013 · Journal of Psychosomatic Research
  46. Physiological and medical findings in insomnia: Implications for diagnosis and care
    Michael H. Bonnet, George G. Burton, Donna L. Arand · 2013 · Sleep Medicine Reviews
  47. Sleep disturbances in a clinical forensic psychiatric population
    Jeanine Kamphuis, Julie Karsten, Al de Weerd, Marike Lancel · 2013 · Sleep Medicine
  48. The Legacy of the Benzodiazepine Receptor
    Hanns Möhler · 2014 · Advances in pharmacology
  49. Untitled work
    2005 · 10.1016/b0-72-160797-7/50126-9
  50. Sleep architecture, cocaine and visual learning
    PETER T. MORGAN, Edward Franz Pace-Schott, Zakir H. Sahul, Vladimir Coric, Robert Stickgold, Robert T. Malison · 2008 · Addiction
  51. The Effect of Eszopiclone in Patients With Insomnia and Coexisting Rheumatoid Arthritis
    Thomas G. Roth, Janet M. Price, David A. Amato, Robert Rubens, James M. Roach, Thomas J. Schnitzer · 2009 · The Primary Care Companion to The Journal of Clinical Psychiatry
  52. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder
    Carl Victor Asche, Vijay N. Joish, FABIAN T. CAMACHO, Christopher Lawrence Drake · 2010 · Current Medical Research and Opinion
  53. Sleep therapeutics and neuropsychiatric illness
    Andrew D. Krystal · 2019 · Neuropsychopharmacology
  54. A Randomized Clinical Trial of Cognitive-Behavioral Therapy for Insomnia to Augment Posttraumatic Stress Disorder Treatment in Survivors of Interpersonal Violence
    Wilfred R. Pigeon, Hugh F. Crean, Catherine Cerulli, Autumn M. Gallegos, Todd M. Bishop, Kathi L. Heffner · 2021 · Psychotherapy and Psychosomatics
  55. Adjunctive Sleep Medications and Depression Outcome in the Treatment of Serotonin-Selective Reuptake Inhibitor Resistant Depression in Adolescents Study
    Wael A. Shamseddeen, Gregory N. Clarke, Martin B. Keller, Karen Dineen Wagner, Boris B. Birmaher, Graham J. Emslie, Neal D. Ryan, Joan Rosenbaum Asarnow, Giovanna Porta, David A. Brent · 2012 · Journal of Child and Adolescent Psychopharmacology
  56. Eszopiclone: its use in the treatment of insomnia
    Jaime M. Monti, Seithikurippu Ratnas Pandi-Perumal · 2007 · Neuropsychiatric Disease and Treatment
  57. Childhood trauma, depression, and sleep quality and their association with psychotic symptoms and suicidality in schizophrenia
    Esin Evren Kılıçaslan, Aslı Tuğba Esen, Meltem I. Kasal, Erdal Ozelci, Murat Boysan, Mustafa Güleç · 2017 · Psychiatry Research
  58. Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
    Markus Dold, Lucie Bartova, J. Mendlewicz, Daniel Souery, Alessandro Serretti, Stefano Porcelli, Joseph Zohar, S.A. Montgomery, S. Kasper · 2018 · Acta Psychiatrica Scandinavica
  59. Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect
    Erich Seifritz, Sandra Schläfke, Edith Holsboer‐Trachsler · 2019 · Journal of Psychiatric Research
  60. Insomnia and the risk for suicide: Does sleep medicine have interventions that can make a difference?
    Wilfred R. Pigeon, Eric D. Caine · 2010 · Sleep Medicine
  61. Enhancing Outcomes from Major Depression: Using Antidepressant Combination Therapies with Multifunctional Pharmacologic Mechanisms from the Initiation of Treatment
    Stahl, Stephen M. · 2010 · CNS Spectrums
  62. Impact of sleep disturbance on patients in treatment for mental disorders
    Kallestad, Håvard, Hansen, Bjarne, Langsrud, Knut, Ruud, Torleif, Morken, Gunnar, Stiles, Tore C, Gråwe, Rolf W · 2012 · BMC Psychiatry
  63. A Randomized, Double-Blind, Placebo-Controlled Trial of Eszopiclone for the Treatment of Insomnia in Patients with Chronic Low Back Pain
    Harold W. Goforth, Xavier Preudʼhomme, Andrew D. Krystal · 2014 · SLEEP
  64. Ramelteon for the treatment of insomnia in menopausal women
    Roseanne D. Dobkin, Matthew A. Menza, Karina Bienfait, Lesley A. Allen, Humberto Marín, Michael A. Gara · 2009 · Menopause international
  65. Effect of depression on sleep: Qualitative or quantitative?
    Ravi M. Gupta, Sushant Dahiya, Manjeet Singh Bhatia · 2009 · Indian Journal of Psychiatry
  66. Magnetic resonance (MR) spectroscopic measurement of γ-aminobutyric acid (GABA) in major depression before and after electroconvulsive therapy
    Marie Krøll Knudsen, Jamie Near, Anne Bastholm Blicher, Poul Videbech, Jakob Udby Blicher · 2018 · Acta Neuropsychiatrica
  67. Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
    Taro Kishi, Michinori Koebis, Michiko Sugawara, Yuka Kawatsu, Takehiro Taninaga, Nakao Iwata · 2024 · Translational Psychiatry
  68. Pharmacologic management of insomnia: past, present, and future.
    D. T. Curry, Rhody D Eisenstein, J. Walsh · 2006 · Psychiatric Clinics of North America
  69. IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder
    Chad D. Rethorst, THOMAS L. GREER, Marisa S.P. Toups, Ira H. Bernstein, Thomas James Carmody, Madhukar H. Trivedi · 2015 · Translational Psychiatry
  70. Sensitivity and Specificity of Polysomnographic Criteria for Defining Insomnia
    Jack D. Edinger, Christi S. Ulmer, Melanie K. Means · 2013 · Journal of Clinical Sleep Medicine
  71. Social class and gender patterning of insomnia symptoms and psychiatric distress: a 20-year prospective cohort study
    Michael James Green, Colin Alexander Espie, Michaela Benzeval · 2014 · BMC Psychiatry
  72. Treating insomnia with medications
    James Frederic Pagel, Seithikurippu Ratnas Pandi-Perumal, Jaime M. Monti · 2018 · Sleep Science and Practice
  73. Menopausal transition and depression: who is at risk and how to treat it?
    Cláudio N. Soares · 2007 · Expert Review of Neurotherapeutics
  74. Insomnia is associated with quality of life impairment in medical-surgical intensive care unit survivors
    Elizabeth C. Parsons, Catherine Lee Hough, Michael V. Vitiello, Douglas Zatzick, Dimitry S. Davydow · 2015 · Heart & Lung
  75. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: A randomized, double-blind, placebo-controlled study
    Esaki, Yuichi, Kitajima, Tsuyoshi, Takeuchi, Ippei, Tsuboi, Soji, Furukawa, Osamu, Moriwaki, Masatsugu, Fujita, Kiyoshi, Iwata, Nakao · 2017 · Chronobiology International
  76. Sleep disturbances and depressive symptoms: an investigation of their longitudinal association in a representative sample of the UK general population
    Petros Skapinakis, Dheeraj Rai, Fotios Anagnostopoulos, S. Harrison, Ricardo Araya, Glyn Lewis · 2012 · Psychological Medicine
  77. Pathophysiology of Insomnia
    Michael H. Bonnet, Donna L. Arand · 2016 · Springer eBooks
  78. Correlations between depression behaviors and sleep parameters after repeated corticosterone injections in rats
    Zijun Wang, Bin Yu, Xueqiong Zhang, Zhao‐Fu Sheng, Shengjie Li, Yuan‐Li Huang, Qing Cao, Xiang‐Yu Cui, Su‐Ying Cui, Yonghe Zhang · 2014 · Acta Pharmacologica Sinica
  79. Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study
    Ryuji Furihata, Rei Otsuki, Naomi Hasegawa, Takashi Tsuboi, Shusuke Numata, Norio Yasui‐Furukori, Hiroko Kashiwagi, Hikaru Hori, Shinichiro Ochi, Hiroyuki Muraoka et al. · 2021 · Sleep Medicine
  80. Insomnia in Patients with Depression
    Ripu Daman Jindal · 2009 · CNS Drugs
  81. Carryover effect on next‐day sleepiness and psychomotor performance of nighttime administered antihistaminic drugs: a randomized controlled trial
    Yasuko Katayose, Sayaka Aritake, Shingo Kitamura, Minori Enomoto, Akiko Hida, Kiyohisa Takahashi, Kazuo Mishima · 2012 · Human Psychopharmacology Clinical and Experimental
  82. Non-Benzodiazepine Receptor Agonists for Insomnia.
    P. Becker, Manya Somiah · 2015 · Sleep Medicine Clinics
  83. Use of Treatment Algorithms for Depression
    Madhukar H. Trivedi, Maurizio Fava M. D, Lauren B. Marangell, David N. Osser, Richard Charles Shelton · 2006 · The Journal of Clinical Psychiatry
  84. Correlations among insomnia symptoms, sleep medication use and depressive symptoms
    Yoko Komada, Takashi Nomura, Masayoshi Kusumi, Kenji Nakashima, Isa Okajima, Taeko Sasai, Yuichi Inoue · 2010 · Psychiatry and Clinical Neurosciences
  85. Self-help behaviors for sleep and depression: A Japanese nationwide general population survey
    Ryuji Furihata, Makoto Uchiyama, Sakae Takahashi, Chisato Konno, Masahiro Suzuki, Kouichi Osaki, Yoshitaka Kaneita, Takashi Ohida · 2010 · Journal of Affective Disorders
  86. Insomnia Diagnosis, Assessment, and Evaluation
    Jason C. Ong, John Todd Arnedt, Philip Gehrman · 2016 · Elsevier eBooks
  87. Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus melatonergic agonism
    Stephen M. Stahl · 2007 · The International Journal of Neuropsychopharmacology
  88. Selecting a pharmacotherapy regimen for patients with chronic insomnia
    Amanda B. Hassinger, Nikolas Bletnisky, Rizwan Dudekula, Ali El-Solh · 2020 · Expert Opinion on Pharmacotherapy
  89. High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder
    Raymond Wing Moon Lam · 2007 · International Clinical Psychopharmacology
  90. Longitudinal effects of nocturnal insomnia symptom subtypes and nonrestorative sleep on the incidence of depression among community-dwelling older adults: results from the Health and Retirement Study
    Tuo‐Yu Chen, Yasuhiko Saito · 2021 · Sleep Medicine
  91. An Update on Assessment, Therapeutic Management, and Patents on Insomnia
    Amit Porwal, Yogesh Chand Yadav, Kamla Pathak, Ramakant Yadav · 2021 · BioMed Research International
  92. Eszopiclone for late-life insomnia.
    Christina S. McCrae, Amanda Ross, Ashley M. Stripling, Natalie D. Dautovich · 2007 · PubMed Central
  93. Low-dose doxepin for the treatment of insomnia: emerging data
    H. Goforth · 2009 · Expert Opinion on Pharmacotherapy
  94. Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications
    Greenblatt, David J, Zammit, Gary K · 2012 · Expert Opinion on Drug Metabolism & Toxicology
  95. Pharmacotherapy of insomnia
    O. Ioachimescu, A. El-Solh · 2008 · Expert Opinion on Pharmacotherapy
  96. What Should Be the Focus of Treatment When Insomnia Disorder Is Comorbid with Depression or Anxiety Disorder?
    Charles M. Morin, Suzanne M. Bertisch, Rafael Pelayo, Nathaniel F. Watson, John Weyl Winkelman, Phyllis C. Zee, Andrew D. Krystal · 2023 · Journal of Clinical Medicine
  97. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers
    Akemi Miyata, Kunihiro Iwamoto, Naoko Kawano, Kunihiro Kohmura, Maeri Yamamoto, Branko Aleksić, Kazutoshi Ebe, Akiko Noda, Yukihiro Noda, Shuji Iritani et al. · 2014 · Psychopharmacology
  98. Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials
    Stephane Borentain, David Williamson, Ibrahim Turkoz, Vanina Popova, William Vaughn McCall, Maju Mathews, Frank Wiegand · 2021 · Neuropsychiatric Disease and Treatment
  99. Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder
    Yuki Shigetsura, Satoshi Imai, Hiroki Endo, Yumi Shimizu, Keita Ueda, Toshiya Murai, Kotaro Itohara, Shunsaku Nakagawa, Atsushi Yonezawa, Yasuaki Ikemi et al. · 2022 · Clinical Neuropharmacology
  100. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
    Daniel F. Kripke · 2018 · F1000Research